Saint Alphonsus Regional Medical Center | |
1055 North Curtis Road, Boise, Idaho 83706 | |
(208) 367-2121 | |
Name | Saint Alphonsus Regional Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 1055 North Curtis Road, Boise, Idaho |
Ownership | Voluntary non-profit - Church |
Emergency Services | Yes |
Medicare ID (CCN) | 130007 |
NPI Number | 1063981488 |
Organization Name | SAINT ALPHONSUS HEALTH SYSTEM INC |
Address | 1055 N Curtis Rd, Boise, ID 83706 |
Hospital Type | Religious Nonmedical Health Care Institution |
Phone Number | 208-367-2121 |
News Archive
Bristol-Myers Squibb (New York, New York) is divesting its 83% majority stake in its last non-biopharmaceutical holding, Mead Johnson Nutritional (Evansville, Indiana).
Yaupon Therapeutics, a privately held specialty pharmaceutical company, today announced positive top-line results from the pivotal multi-center study of its lead product candidate, a proprietary topical mechlorethamine gel for the treatment of early-stage cutaneous T-cell lymphoma (CTCL - stages I-IIa). The top-line data show that the study, which was conducted under a Special Protocol Assessment (SPA), achieved its primary and secondary endpoints.
A rise in addiction and overdose deaths involving opioids in the United States has spurred a series of initiatives focused on reducing opioid risks, including several related to prescription of opioids in care of pain.
Cancer patients about to undergo pelvic radiotherapy or who have had the treatment and are experiencing some of the potentially worrying and embarrassing side effects, now have a new free resource to turn to thanks to Cancerbackup and Cancer Research UK.
› Verified 8 days ago
NPI Number | 1184155426 |
Organization Name | SAINT ALPHONSUS REGIONAL MEDICAL CENTER INC |
Doing Business As | SAINT ALPHONSUS RMC TVL |
Address | 1055 N Curtis Rd, Boise, ID 83706 |
Hospital Type | General Acute Care Hospital |
Phone Number | 208-367-4148 |
News Archive
Bristol-Myers Squibb (New York, New York) is divesting its 83% majority stake in its last non-biopharmaceutical holding, Mead Johnson Nutritional (Evansville, Indiana).
Yaupon Therapeutics, a privately held specialty pharmaceutical company, today announced positive top-line results from the pivotal multi-center study of its lead product candidate, a proprietary topical mechlorethamine gel for the treatment of early-stage cutaneous T-cell lymphoma (CTCL - stages I-IIa). The top-line data show that the study, which was conducted under a Special Protocol Assessment (SPA), achieved its primary and secondary endpoints.
A rise in addiction and overdose deaths involving opioids in the United States has spurred a series of initiatives focused on reducing opioid risks, including several related to prescription of opioids in care of pain.
Cancer patients about to undergo pelvic radiotherapy or who have had the treatment and are experiencing some of the potentially worrying and embarrassing side effects, now have a new free resource to turn to thanks to Cancerbackup and Cancer Research UK.
› Verified 8 days ago
NPI Number | 1952739765 |
Organization Name | SAINT ALPHONSUS REGIONAL MEDICAL CENTER |
Address | 1055 N Curtis Rd, Attention Pharmacy, Boise, ID 83706 |
Hospital Type | General Acute Care Hospital |
Phone Number | 208-367-2166 |
News Archive
Bristol-Myers Squibb (New York, New York) is divesting its 83% majority stake in its last non-biopharmaceutical holding, Mead Johnson Nutritional (Evansville, Indiana).
Yaupon Therapeutics, a privately held specialty pharmaceutical company, today announced positive top-line results from the pivotal multi-center study of its lead product candidate, a proprietary topical mechlorethamine gel for the treatment of early-stage cutaneous T-cell lymphoma (CTCL - stages I-IIa). The top-line data show that the study, which was conducted under a Special Protocol Assessment (SPA), achieved its primary and secondary endpoints.
A rise in addiction and overdose deaths involving opioids in the United States has spurred a series of initiatives focused on reducing opioid risks, including several related to prescription of opioids in care of pain.
Cancer patients about to undergo pelvic radiotherapy or who have had the treatment and are experiencing some of the potentially worrying and embarrassing side effects, now have a new free resource to turn to thanks to Cancerbackup and Cancer Research UK.
› Verified 8 days ago
NPI Number | 1992736649 |
Organization Name | SAINT ALPHONSUS REGIONAL MEDICAL CENTER INC |
Doing Business As | SAINT ALPHONSUS ACUTE CARE |
Address | 1055 N Curtis Rd, Boise, ID 83706 |
Hospital Type | General Acute Care Hospital |
Phone Number | 208-367-4148 |
News Archive
Bristol-Myers Squibb (New York, New York) is divesting its 83% majority stake in its last non-biopharmaceutical holding, Mead Johnson Nutritional (Evansville, Indiana).
Yaupon Therapeutics, a privately held specialty pharmaceutical company, today announced positive top-line results from the pivotal multi-center study of its lead product candidate, a proprietary topical mechlorethamine gel for the treatment of early-stage cutaneous T-cell lymphoma (CTCL - stages I-IIa). The top-line data show that the study, which was conducted under a Special Protocol Assessment (SPA), achieved its primary and secondary endpoints.
A rise in addiction and overdose deaths involving opioids in the United States has spurred a series of initiatives focused on reducing opioid risks, including several related to prescription of opioids in care of pain.
Cancer patients about to undergo pelvic radiotherapy or who have had the treatment and are experiencing some of the potentially worrying and embarrassing side effects, now have a new free resource to turn to thanks to Cancerbackup and Cancer Research UK.
› Verified 8 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Bristol-Myers Squibb (New York, New York) is divesting its 83% majority stake in its last non-biopharmaceutical holding, Mead Johnson Nutritional (Evansville, Indiana).
Yaupon Therapeutics, a privately held specialty pharmaceutical company, today announced positive top-line results from the pivotal multi-center study of its lead product candidate, a proprietary topical mechlorethamine gel for the treatment of early-stage cutaneous T-cell lymphoma (CTCL - stages I-IIa). The top-line data show that the study, which was conducted under a Special Protocol Assessment (SPA), achieved its primary and secondary endpoints.
A rise in addiction and overdose deaths involving opioids in the United States has spurred a series of initiatives focused on reducing opioid risks, including several related to prescription of opioids in care of pain.
Cancer patients about to undergo pelvic radiotherapy or who have had the treatment and are experiencing some of the potentially worrying and embarrassing side effects, now have a new free resource to turn to thanks to Cancerbackup and Cancer Research UK.
› Verified 8 days ago
St Luke's Regional Medical Center Acute Care Hospital Location: 190 East Bannock Street, Boise, Idaho 83712 Phone: (208) 381-2222 | |
Saint Alphonsus Regional Medical Center Acute Care Hospital Location: 1055 North Curtis Road, Boise, Idaho 83706 Phone: (208) 367-2121 | |
Treasure Valley Hospital Acute Care Hospital Location: 8800 West Emerald Street, Boise, Idaho 83704 Phone: (208) 373-5000 | |
Intermountain Hospital Psychiatric Hospital Location: 303 North Allumbaugh Street, Boise, Idaho 83704 Phone: (208) 377-8400 | |
Lifeways Hospital Psychiatric Hospital Location: 8050 West Northview Street, Boise, Idaho 83704 Phone: (208) 327-0504 |